Day Zero Diagnostics
Product development leader developing cutting edge solutions in medical technologies and diagnostics. Expertise in molecular diagnostics instrumentation and consumables. Built and led multi-disciplinary teams from concept to commercialization. Earned a BS in Mechanical Engineering from University of Massachusetts and MS in Engineering Management from Tufts University.
This person is not in any offices
Day Zero Diagnostics
The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.